Comparison of Ultrasound and Hysterosalpingography in Evaluation of Uterine Abnormality in Patients With Infertility

January 6, 2025 updated by: Muhammad Naveed Babur, Superior University

Comparison of Ultrasound and Hysterosalpingography in Evaluation of Uterine Abnormality in Patients With Primary and Secondary Infertility

The leading issue that every couple is experiencing in present era is infertility and it has become the major problem worldwide. Many hormonal disorders, weight, diet, and uterine abnormalities contributes in infertility.

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Detailed Description

To Compare diagnostic effectiveness of Ultrasound and Hysterosalpingography in detecting uterine abnormalities among Primary and Secondary Infertile women.

In order to obtain the necessary results, 73 patients were examined on Ultrasound and then referred for Hysterosalpingography at Radiology Department of Dr.Essa Lab and Punjab Radiology. Patients with Primary and secondary infertility between the age of 18 to 45 were included whereas pregnant women and women with PID and GTI were excluded. The data were collected utilizing the questionnaire and then processed in SPSS version 25.

Study Type

Observational

Enrollment (Actual)

3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Pakistan
    • Punjab
      • Lahore, Punjab, Pakistan
        • Dr. Essa Lab, High Q tower, Jail Road Lahore"

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

primary and secondary infertile women using Ultrasound and Hysterosalpingography in Evaluation of Uterine Abnormality

Description

Inclusion Criteria:

  • primary and secondary infertile women

Exclusion Criteria:

  • Pregnant women. Women with PID

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
2D Ultrasound Scan
Time Frame: 12 Months
Uterine anomalies can be diagnosed on routine two-dimensional ultrasound scan
12 Months
Hysterosalpingography test
Time Frame: 12 Months
HSG is an x-ray exam of the uterus and fallopian tubes. It uses a special form of x-ray called fluoroscopy and a contrast materia.
12 Months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Superior University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 28, 2024

Primary Completion (Actual)

July 1, 2024

Study Completion (Estimated)

March 1, 2025

Study Registration Dates

First Submitted

December 17, 2024

First Submitted That Met QC Criteria

January 6, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 6, 2025

Last Verified

January 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • MSAHS/Batch-Spring23/012

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Uterine Abnormality

Clinical Trials on Ultrasound

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ecuador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe